Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical pharmacokinetics of caspofungin in critically ill patients
2006-004106-87Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Oct 2007
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of caspofungin in invasive mycoses (2 cohorts), sponsored by Medical University of Innsbruck. Primary endpoint: Plasma caspofungin concentrations with/without hemofiltration. Started Oct 2007; status: completed.
02
Drugs
caspofungin
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2006-004106-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004106-87.